by admin | May 15, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Michael Irving – News Atlas Scientists in Canada have developed a new technique that may one day help restore some sight to patients with inherited vision impairment. The regenerative therapy works by expressing genes that convert dormant cells into new...
by admin | May 14, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
by Physician’s Weekly Mesenchymal stem cell-neural progenitor therapy (MSC-NPs) are bone marrow-derived cells with trophic and immunomodulatory properties. Their therapeutic potential in MS was evaluated in a randomized, double-blind, placebo-controlled phase 2...
by admin | May 13, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
STING-seq provides roadmap to identify variants and genes, enabling deeper understanding of the noncoding genome and targets for therapies By NYU News A major challenge in human genetics is understanding which parts of the genome drive specific traits or contribute to...
by admin | May 12, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
by Justin Jackson – Phys.org Researchers at Sana Biotechnology, Inc., in California, have made a significant breakthrough in realizing the promise of stem cell therapy: stem cells that do not trigger an immune response from an immunologically incompatible donor....
by admin | May 10, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Longeveron MIAMI, May 09, 2023 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing regenerative medicines for unmet medical needs, today announced new...
